New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
06:26 EDTJCPJ.C. Penney option implied volatility is elevated
J.C. Penney option implied volatility is elevated, near the upper end of its 52-week range according to iVolatility.
News For JCP From The Last 14 Days
Check below for free stories on JCP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent JCP news | >>
August 25, 2014
12:16 EDTJCPJ.C. Penney rises, levels to watch
The stock is holding above what was strong resistance at the $10 area. JPMorgan earlier recommended the shares as a long idea, and the stock is up over 4.6% on greater than average daily volume to $10.65. At that price, next resistance is at $11.22. Support is at $10.42.
10:16 EDTJCPJ.C. Penney rises after analyst predicts more store closures coming
Subscribe for More Information
07:37 EDTJCPJ.C. Penney recommneded as a Long Trade Idea at JPMorgan
Subscribe for More Information
August 21, 2014
10:35 EDTJCPSears falls after reporting Q2 loss that more than doubled analyst projections
Subscribe for More Information
10:22 EDTJCPOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD VHC ACHN JCP WB JD YPF
August 20, 2014
11:42 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
05:51 EDTJCPStocks with implied volatility movement; JCP VHC
Subscribe for More Information
August 19, 2014
10:42 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
August 18, 2014
11:57 EDTJCPStocks with call strike movement; JCP GPRO
J.C. Penney (JCP) November 11 call option implied volatility decreased 4% to 43, GoPro (GPRO) January 48 call option implied volatility decreased 8% to 45 according to IVolatility.
August 15, 2014
17:02 EDTJCPStocks end week slightly higher despite flare-up in Russian tensions
Subscribe for More Information
16:38 EDTJCPOn The Fly: Closing Wrap
Stocks on Wall Street began the session in positive territory despite some soft economic data points, including a weaker than expected report on manufacturing in the New York area and a lower than expected consumer confidence reading. The market short circuited following reports of a skirmish in the Ukraine where a Russian convoy was supposedly fired upon when it crossed the border. The averages quickly dropped and were only able to partially recover, as investors moved to the sidelines to avoid additional geopolitical risk over the weekend. ECONOMIC EVENTS: The NY Fed's Empire manufacturing survey had a reading of 14.69, versus expectations for a 20.0 reading. The Producer Price Index increased 0.1% overall, matching expectations. The core reading was up 0.2%, which was also in-line with the consensus forecast. Industrial production increased 0.4% in July, beating the consensus 0.2% growth forecast. That nudged up capacity utilization to 79.2%, versus 79.1% previously. The first University of Michigan consumer confidence reading for August fell 2.6 points to 79.2, versus expectations for it to have edged up to 82.0. Treasury international capital data showed foreigners dumped $153.5B in total U.S. assets in July after buying a revised $33.1B in June. COMPANY NEWS: Shares of Monster Beverage (MNST) surged $21.84, or 30.48%, to $93.49 after Coca-Cola (KO) bought a stake in the energy drink maker and the companies announced a long-term strategic partnership and asset swap. Coca-Cola will pay $2.15B for a 16.7% stake in Monster, the companies announced last night. Under the terms of their agreement, Coca-Cola will add two directors to Monster's board. Coke will transfer ownership of its worldwide energy business including brands like NOS, Full Throttle, Burn, Mother, Play and Power Play, and Relentless to Monster, in trade for which Monster will transfer its non-energy business to Coke. MAJOR MOVERS: Among the notable gainers was Achillion Pharmaceuticals (ACHN), which rose 81c, or 9.6%, to $9.25 after the company announced interim results from an ongoing Phase 2 proxy study of a potential chronic hepatitis C virus regimen that analysts at Piper Jaffray called "impressive." Also higher was Paylocity (PCTY), which advanced $2.17, or 9.79%, to $24.34 after reporting better than expected fourth quarter revenue and guiding to higher than expected sales in its first quarter. Among the noteworthy losers was retailer J.C. Penney (JCP), which fell 24c, or 2.46%, to $9.50 despite posting a narrower than expected loss for the second quarter. Also lower were shares of another department store owner, Dillard's (DDS), which dropped $9.49, or 8.21%, to $106.11 after reporting quarterly results that missed expectations. INDEXES: The Dow dropped 50.67, or 0.3%, to 16,662.91, the Nasdaq gained 11.92, or 0.27%, to 4,464.93, and the S&P 500 slipped 0.12, or 0.01%, to 1,955.06.
12:53 EDTJCPStocks with call strike movement; JCP SINA
Subscribe for More Information
12:39 EDTJCPOn The Fly: Midday Wrap
Subscribe for More Information
10:30 EDTJCPJ.C. Penney falls despite posting a narrower than expected Q2 loss
Subscribe for More Information
09:35 EDTJCPActive equity options trading on open
Subscribe for More Information
09:10 EDTJCPOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTJCPJ.C. Penney comps get more difficult from here, says Maxim
Subscribe for More Information
08:47 EDTJCPJ.C. Penney comp run rates does not support quick recovery, says Morgan Stanley
Morgan Stanley said J.C. Penney's underlying comp run-rate of 4% does not support a quick turnaround and believes comps will decelerate from current levels. The firm trimmed its 2015-2017 base assumptions and believes the company will struggle to reach +6% comps. Shares are Underweight rated with a reduced price target of $7 from $7.50.
07:19 EDTJCPWells says 'no reason to get too excited' about J.C. Penney
Subscribe for More Information
06:41 EDTJCPJ.C. Penney turnaround 'very much underway,' says Piper Jaffray
Subscribe for More Information
1 | 2 | all recent JCP news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use